Bicycle Therapeutics (BCYC) is a biotechnology company based in the United Kingdom that focuses on developing novel therapeutics based on bicycle peptide technology. This technology enables the creation of small, stable, and highly specific therapeutics with the potential to treat various diseases, including cancer and immune-related disorders. Bicycle Therapeutics is dedicated to developing drugs based on its bicycle peptide platform and building partnership agreements with pharmaceutical companies.